- U.S. Food & Drug Administration and European Medicines Agency approve first trastuzumab biosimilars
- U.S. Food & Drug Administration approves a second infliximab biosimilar
As pharmaceutical drug costs attract increasing media attention and political scrutiny, a growing number of biosimilar drugs are set to enter the U.S. and European markets in the coming years. Global sales